Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Chemical CofiledCriticalDow Chemical Co
Priority to ARP010102874ApriorityCriticalpatent/AR035576A1/es
Publication of AR035576A1publicationCriticalpatent/AR035576A1/es
Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
Y02P20/00—Technologies relating to chemical industry
Y02P20/50—Improvements relating to the production of bulk chemicals
Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Landscapes
Micro-Organisms Or Cultivation Processes Thereof
(AREA)
Abstract
La presente provee un método para la elaboración de una glicoproteína que tiene una cadena de azúcar de tipo humano que comprende una etapa en la cual se obtiene una célula de planta de un gen de glicosiltransferasa y el gen de un glicoproteína exógena y una etapa en la cual la célula de planta transformada obtenida es cultivada. Reivindicación 12: Una planta recombinante, o una porción de la misma, que produce glicoproteínas similares a mamíferos que no comprenden ni fucosa ni xilosa.
ARP010102874A2001-06-152001-06-15Un metodo para la elaboracion de glicoproteinas que tienen una glucosilacion de tipo humano
AR035576A1
(es)
Derivados da ciclosporina em que a sequencia peptidica contem pelo menos um aminoacido nao natural do tipo pseudo-prolina e metodo para preparacao dos mesmos
Vector viral que contem um gene que codifica para uma das glicoproteinas (gp) do involucro do virus responsavel pela s.i.d.a. e anticorpos contra essas glicoproteinas